Sphera Global Healthcare Fund logo

Sphera Global Healthcare Fund

Asia, Tel Aviv, Israel, Tel Aviv

Description

Sphera Global Healthcare Fund is a long/short equity fund that is focused on the global pharmaceutical and biotech industries.

Investor Profile

Sphera Global Healthcare Fund has backed more than 27 startups, with 4 new investments in the last 12 months alone. The firm has led 1 rounds, about 4% of its total and boasts 23 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity, Series B, Series E rounds (top funding stages).
  • Majority of deals are located in United States, Canada, China.
  • Strong thematic focus on Biotechnology, Pharmaceutical, Health Care.

Stage Focus

  • Post Ipo Equity (67%)
  • Series B (15%)
  • Series E (7%)
  • Series C (4%)
  • Series Unknown (4%)
  • Series A (4%)

Country Focus

  • United States (52%)
  • Canada (22%)
  • China (7%)
  • Sweden (7%)
  • Switzerland (4%)
  • United Kingdom (4%)
  • Israel (4%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Therapeutics
  • Medical
  • Biopharma
  • Life Science
  • Health Diagnostics
  • Neuroscience
  • Genetics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sphera Global Healthcare Fund frequently co-invest with?

Altium Capital
North America, New York, United States, New York
Co-Investments: 4
CA
North America, Massachusetts, United States, Boston
Co-Investments: 5
DC
North America, Illinois, United States, Chicago
Co-Investments: 4
Woodline Partners
North America, California, United States, San Francisco
Co-Investments: 6
Avidity Partners
North America, Texas, United States, Dallas
Co-Investments: 4
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 9
Ally Bridge Group
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 5
Great Point Partners
North America, Connecticut, United States, Greenwich
Co-Investments: 4
Deep Track Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 5
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 5

What are some of recent deals done by Sphera Global Healthcare Fund?

Sensorion

Clapiers, Languedoc-Roussillon, France

Sensorion is a France-based biopharmaceutical company developing targeted therapeutic solutions for the treatment of vestibular deficits.

BiopharmaBiotechnologyHealth CareTherapeutics
Post Ipo EquityJan 28, 2026
Amount Raised: $71,459,878
Eledon Pharmaceuticals

Irvine, California, United States

Eledon Pharmaceuticals is a biotechnology company developing treatments for people undergoing organ or cellular transplantation.

BiotechnologyHealth CareMedicalPharmaceutical
Post Ipo EquityOct 29, 2024
Amount Raised: $85,000,000
enGene

Vancouver, British Columbia, Canada

enGene is a biotechnology company develops treatment for mucosal diseases through inducing therapeutic proteins of harmful proteins.

BiotechnologyDiabetesGeneticsHealth Care
Post Ipo EquityOct 25, 2024
Amount Raised: $43,188,771
ProMIS Neurosciences

Toronto, Ontario, Canada

ProMIS Neurosciences develops therapeutic products and diagnostic devices targeting misfolded protein diseases.

BiotechnologyHealth DiagnosticsMedicalNeuroscienceTherapeutics
Post Ipo EquityJul 26, 2024
Amount Raised: $30,300,000
Chemomab

Tel Aviv, Tel Aviv, Israel

Chemomab is a clinical-stage biotech company focusing on the discovery and development of innovative therapeutics.

BiotechnologyHealth CarePharmaceutical
Post Ipo EquityJul 25, 2024
Amount Raised: $10,000,000
Hansa Biopharma

Lund, Skane Lan, Sweden

Hansa Biopharma is a biopharmaceutical company that develops immunomodulatory treatments for people living with rare immunological diseases.

BiotechnologyHealth Care
Post Ipo EquityApr 12, 2024
Amount Raised: $34,222,770
Cybin

Toronto, Ontario, Canada

Cybin is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.

BiotechnologyHealth CareMental HealthPharmaceutical
Post Ipo EquityMar 13, 2024
Amount Raised: $150,000,000
Aprea

Stockholm, Stockholms Lan, Sweden

Aprea is a biopharmaceutical company that develops novel cancer therapeutics.

BiotechnologyHealth CareMedicalPersonal HealthPharmaceutical
Post Ipo EquityMar 11, 2024
Amount Raised: $16,000,000
Neurona Therapeutics

San Francisco, California, United States

Neurona Therapeutics develops cell therapies for neurological disorders, focusing on treatments like NRTX-1001 for epilepsy.

BiotechnologyHealth CareTherapeutics
Series EFeb 8, 2024
Amount Raised: $120,000,000
Skye Bioscience

San Diego, California, United States

Skye Bioscience is a pharmaceutical company developing new therapeutic outcomes for diseases.

BiotechnologyMedicalPharmaceutical
Post Ipo EquityJan 29, 2024
Amount Raised: $50,250,000

Find More Investors Like Sphera Global Healthcare Fund

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Sphera Global Healthcare Fund | Pipeseed